APA (7th ed.) Citation

Dan, G., Agewall, S., & Borggrefe, M. (2018). Antiarrhythmic drugs-clinical use and clinical decision making: A consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP). Europace, 20(5), . https://doi.org/10.1093/europace/eux373

Chicago Style (17th ed.) Citation

Dan, Gheorghe-Andrei, Stefan Agewall, and Martin Borggrefe. "Antiarrhythmic Drugs-clinical Use and Clinical Decision Making: A Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, Endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP)." Europace 20, no. 5 (2018). https://doi.org/10.1093/europace/eux373.

MLA (9th ed.) Citation

Dan, Gheorghe-Andrei, et al. "Antiarrhythmic Drugs-clinical Use and Clinical Decision Making: A Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, Endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP)." Europace, vol. 20, no. 5, 2018, https://doi.org/10.1093/europace/eux373.